Alkermes
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction, multiple sclerosis and oncology. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.
LinkedIn:
Twitter:
Media Releases
Apr 12, 2021 11:40 AM ET
Apr 8, 2021 1:35 PM ET
Apr 7, 2021 2:10 PM ET
Apr 6, 2021 1:05 PM ET
Apr 5, 2021 12:20 PM ET
- 1 of 12
- next ›
Recent Video
Apr 6, 2021 1:05 PM ET |
Apr 5, 2021 12:20 PM ET |
Mar 31, 2021 1:25 PM ET |
Recent Audio
Mar 10 |